Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia
Sponsor: MeiraGTx, LLC
Summary
This study is a long-term follow-up study for patients who have been administered AAV2hAQP1 in the Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity in Subjects with Radiation Induced Parotid Gland Hypofunction and Xerostomia
Official title: Long-Term Follow-Up Study of Participants Enrolled in the MGT016 Phase 1, Open-Label, Dose-Escalation Study of AAV2hAQP1 for Radiation-Induced Parotid Gland Hypofunction and Xerostomia
Key Details
Gender
All
Age Range
18 Years - 81 Years
Study Type
OBSERVATIONAL
Enrollment
22
Start Date
2020-11-12
Completion Date
2027-03
Last Updated
2025-05-22
Healthy Volunteers
Not specified
Conditions
Locations (4)
Leland Stanford Junior University
Stanford, California, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Atrium Health
Charlotte, North Carolina, United States
Health Sciences North - Northeast Cancer Center
Greater Sudbury, Ontario, Canada